Natera

Yahoo Finance • 2 days ago

Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study

Natera, Inc. (NASDAQ:NTRA) is one of the High Growth Large Cap Stocks to Buy Right Now.On December 18, the company announced publication of the findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology. CAL... Full story

Yahoo Finance • 12 days ago

Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, December 22, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San F... Full story

Yahoo Finance • 18 days ago

Liberty All-Star® Growth Fund, Inc. November 2025 Monthly Update

BOSTON, December 15, 2025--(BUSINESS WIRE)--Below is the November 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, November 2025 Investment Approa... Full story

Yahoo Finance • 18 days ago

SPYM, DRKY: Big ETF Inflows

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the State Street Investment Management, which added 27,150,000 units, or a 2.2% increase week over week. Among... Full story

Yahoo Finance • 22 days ago

Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks

Neilson Barnard / Getty Images Entertainment via Getty Images Quick Read Natera (NTRA) grew revenue 34.66% year-over-year in Q3 2025 and has rallied nearly 70% since Q3 2025. Druckenmiller holds $517.4M in Natera. Insmed (INSM) revenue s... Full story

Yahoo Finance • 23 days ago

Natera Unveils MRD Data From Phase III PALLAS Trial In HR+/HER2- Breast Cancer

(RTTNews) - Natera Inc. (NTRA) announced initial translational research results from the international randomized Phase III PALLAS study. The findings were presented at the San Antonio Breast Cancer Symposium (SABCS) and highlight the prog... Full story

Yahoo Finance • last month

New Amazon Bedrock AgentCore Capabilities Power the Next Wave of Agentic AI Development

Latest AgentCore innovations help customers build, deploy, and scale production-ready AI agents with confidence LAS VEGAS, December 02, 2025--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company... Full story

Yahoo Finance • last month

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks

Key Points Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third quarter all in the sector. Biotec... Full story

Yahoo Finance • last month

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help... Full story

Yahoo Finance • last month

This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.

Neilson Barnard / Getty Images Entertainment via Getty Images Quick Read Druckenmiller produced 30% average annual returns with no losing years at Duquesne from 1981 to 2010. Natera (NTRA) revenue rose 35% year-over-year in Q3 2025 and b... Full story

Yahoo Finance • 2 months ago

Stanley Druckenmiller's Strategic Moves: Exiting Philip Morris International Inc with a -3. ...

This article first appeared on GuruFocus. Insights into Stanley Druckenmiller (Trades, Portfolio)'s Third Quarter 2025 Portfolio Adjustments Warning! GuruFocus has detected 6 Warning Signs with NTRA. Is NTRA fairly valued? Test your thes... Full story

Yahoo Finance • 2 months ago

Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin

Earnings Call Insights: Natera, Inc. (NTRA) Q3 2025 MANAGEMENT VIEW * CEO Steve Chapman reported "We had a fantastic quarter. We generated $592 million in revenue, which is up about 35% over Q3 of last year." Chapman emphasized record... Full story

Yahoo Finance • 2 months ago

Natera GAAP EPS of -$0.64 misses by $0.27, revenue of $592.2M beats by $77.43M

* Natera press release [https://seekingalpha.com/pr/20297814-natera-reports-third-quarter-2025-financial-results] (NTRA [https://seekingalpha.com/symbol/NTRA]): Q3 GAAP EPS of -$0.64 misses by $0.27. * Revenue of $592.2M (+34.7% Y/Y) b... Full story

Yahoo Finance • 2 months ago

After-Hours Earnings Report for November 6, 2025 : MNST, EOG, ABNB, TTWO, WPM, XYZ, ED, MCHP, MTD, NTRA, EXPE, PBA

The following companies are expected to report earnings after hours on 11/06/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Monster Beverage Corporation (MNST)is reporting for the quarter ending Septem... Full story

Yahoo Finance • 3 months ago

Patient Opportunity Equity strategy buys UNH, CROX, MAT, IAC, and BIIB

[Q3 - 3rd Quarter Period write on sticky notes isolated on Office Desk. Stock market concept] syahrir maulana * Patient Opportunity Equity Strategy outperformed in Q3, rising 14.1% versus the S&P 500’s 8.1% return. This brings the fund'... Full story

Yahoo Finance • 3 months ago

Humana initiated, Paycom upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Paycom (PAYC) to Buy... Full story

Yahoo Finance • 4 months ago

Discover September 2025's Stocks That May Be Trading Below Estimated Value

As of September 2025, the U.S. stock market is experiencing a mixed performance, with the S&P 500 and Nasdaq reaching new closing highs while the Dow Jones Industrial Average sees a decline ahead of key inflation data releases. In this env... Full story

Yahoo Finance • 4 months ago

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story

Yahoo Finance • 4 months ago

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. (NASDAQ:NTRA) asserted against NeoGenomics, Inc.'s (NASDAQ:NEO) v1.1 RaDaR test. Natera s... Full story

Yahoo Finance • 4 months ago

Stocks making the biggest moves midday: Petco Health, Celsius, Affirm, Caterpillar & more

Check out the companies making the biggest moves midday: Petco Health & Wellness — The pet store and veterinary services provider surged 22% after raising its full-year adjusted EBITDA guidance. Second-quarter earnings per share topped ana... Full story